Leukemia Real-World Genomic Testing and Treatment Patterns for Adult Patients Newly Diagnosed With Leukemia
Leukemia Pirtobrutinib in Pretreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Leukemia ASCO 2023: Patient Outcomes Following Brexucabtagene Autoleucel for Relapsed/Refractory B-Cell ALL
Leukemia ASCO 2023: Ibrutinib/Obinutuzumab With and Without Venetoclax in Previously Untreated Older Patients With CLL
Leukemia Neighborhood Disadvantage, Health Status, and Health-Care Utilization After Blood or Marrow Transplant
Leukemia ASH 2022: Impact of Momelotinib on Patient-Reported Quality of Life for Patients With Myelofibrosis
Leukemia ASCO 2022: What Factors May Contribute to Asparaginase-Associated Toxicities During ALL Induction Therapy?
Gynecologic Cancers ESMO 2023: Adding a PARP Inhibitor to Chemoimmunotherapy in Advanced Endometrial Cancer
Genitourinary Cancers Radiopharmaceuticals for Treatment of Metastatic Castration-Resistant Prostate Cancer
